Cargando…

Favorable Event Free-Survival of High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Higher Risk Diffuse Large B-Cell Lymphoma in First Complete Remission

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has been applied to patients with diffuse large Bcell lymphoma (DLBCL); it is well established that ASCT shows significant survival benefits for chemosensitive relapse. However, half of relapsed patients are resistant to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneko, Hiroto, Tsutsumi, Yasuhiko, Fujino, Takahiro, Kuwahara, Saeko, Ohshiro, Muneo, Iwai, Toshiki, Kuroda, Junya, Yokota, Shouhei, Horiike, Shigeo, Taniwaki, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508550/ https://www.ncbi.nlm.nih.gov/pubmed/26330999 http://dx.doi.org/10.4081/hr.2015.5812

Ejemplares similares

Inversion of chromosome 7q22 and q36 as a sole abnormality presenting in myelodysplastic syndrome: a case report
por: Kaneko, Hiroto, et al.
Publicado: (2014)

Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome
por: Shimura, Yuji, et al.
Publicado: (2014)

Hairy B-Cell Lymphoproliferative Disorder and its Differential Diagnosis: a Case with Long-Term Follow-Up
por: Matsuda, Kensuke, et al.
Publicado: (2017)

Expression of Master Regulators of T-cell, Helper T-cell and Follicular Helper T-cell Differentiation in Angioimmunoblastic T-cell Lymphoma
por: Matsumoto, Yosuke, et al.
Publicado: (2017)

Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma
por: Matsumura‐Kimoto, Yayoi, et al.
Publicado: (2020)

Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling
por: Taniwaki, Masafumi, et al.
Publicado: (2018)

Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy
por: Mizuno, Yoshimi, et al.
Publicado: (2018)

Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma
por: Fujibayashi, Yuto, et al.
Publicado: (2020)

Extranodal marginal zone lymphoma of the uterine cervix with concomitant copy number gains of the MALT1 and BCL2 genes: A case report
por: Takimoto, Tomoko, et al.
Publicado: (2017)

Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
por: Tanba, Kazuna, et al.
Publicado: (2018)

Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy
por: Kaneko, Hiroto, et al.
Publicado: (2022)

Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib
por: Sakiyama, Emiko, et al.
Publicado: (2020)

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab
por: Kuwahara-Ota, Saeko, et al.
Publicado: (2018)

Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission
por: Chen, Juan, et al.
Publicado: (2022)

Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell lymphoma
por: Matsumoto, Yosuke, et al.
Publicado: (2021)

The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
por: Kobayashi, T, et al.
Publicado: (2016)

8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia
por: Chinen, Yoshiaki, et al.
Publicado: (2014)

Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib‐based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients
por: Kawaji‐Kanayama, Yuka, et al.
Publicado: (2021)

High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif
por: Tsukamoto, Taku, et al.
Publicado: (2017)

Chromosome Abnormalities of Gastric Cancer Detected in Cancerous Effusions
por: Misawa, Shinichi, et al.
Publicado: (1990)

Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function
por: Kaneko, Tomohiro, et al.
Publicado: (2010)

Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome
por: Tatekawa, Shotaro, et al.
Publicado: (2015)

Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission
por: Terao, Toshiki, et al.
Publicado: (2021)

Fetal thymus graft enables recovery from age-related hearing loss and expansion of CD4-Positive T cells expressing IL-1 receptor type 2 and regulatory T Cells
por: Iwai, Hiroshi, et al.
Publicado: (2015)

Remission of severe myasthenia gravis after autologous stem cell transplantation
por: Schlatter, Monica I., et al.
Publicado: (2023)

Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial
por: Kobayashi, Tsutomu, et al.
Publicado: (2022)

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

High tibial osteotomy for medial meniscus posterior root tears in knees with moderate varus alignment can achieve favorable clinical outcomes
por: Itou, Junya, et al.
Publicado: (2022)

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA
por: Kawaji-Kanayama, Yuka, et al.
Publicado: (2023)

Complete remission of two canine cases with precursor-targeted immune-mediated anemia after combination therapy with prednisolone, cyclosporine, and oclacitinib
por: Yuki, Masashi, et al.
Publicado: (2023)

The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
por: Hirabayashi, Yasuhiko, et al.
Publicado: (2012)

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis
por: Rubin, David T., et al.
Publicado: (2015)

Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes
por: Yu, Sijian, et al.
Publicado: (2021)

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
por: Westers, Theresia M., et al.
Publicado: (2005)

HTLV-1 Rex Tunes the Cellular Environment Favorable for Viral Replication
por: Nakano, Kazumi, et al.
Publicado: (2016)

Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study
por: Tanaka, Yoshiya, et al.
Publicado: (2022)

Favorable long-term clinical and radiologic outcomes with high survivorship after autologous osteochondral transplantation of the talus
por: Winkler, Philipp W., et al.
Publicado: (2022)

Gastric perforation caused by secondary systemic amyloidosis
por: Yamamoto, Hiroto, et al.
Publicado: (2021)

Gastric lymphoma complicated by phlegmonous gastritis and Guillain–Barré syndrome: A case report
por: Kuriyama, Kodai, et al.
Publicado: (2020)

Failure to detect autologous antibodies in the remission sera of patients with AML: complications introduced by the presence of rheumatoid factor.
por: James, S. E., et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_dd0d0horbftt5ar5t60c2jiqgg